Criteo Reports Record Q4 and Full-Year 2024 Results, Raises Share Buyback Authorization

CRTO
November 01, 2025

Criteo S.A. announced its financial results for the fourth quarter and full fiscal year ended December 31, 2024, on February 5, 2025. For Q4 2024, revenue was $553 million, a 2% decrease year-over-year, while Contribution ex-TAC increased 6% to $334 million, or 7% at constant currency. Net income for the quarter rose 16% to $72 million, with diluted EPS at $1.23.

For the full fiscal year 2024, Criteo reported revenue of $1.9 billion, a 1% decrease year-over-year, but a 0.4% increase at constant currency. Contribution ex-TAC for the year grew 10% to $1.1 billion, or 11% at constant currency. Net income for fiscal year 2024 significantly increased by 110% to $115 million, resulting in diluted EPS of $1.90.

Adjusted EBITDA for Q4 2024 was $144 million, up 4% year-over-year, and for the full year 2024, it reached $390 million, a 29% increase. The company generated $146 million in Free Cash Flow in Q4 and $182 million for the full year. Criteo deployed a record $225 million for share repurchases in 2024, and its Board of Directors authorized an increase of the share repurchase program to up to $805 million, with $200 million remaining as of January 31, 2025.

Criteo provided guidance for fiscal year 2025, expecting Contribution ex-TAC to grow in the mid-single-digit range year-over-year. For the first quarter of 2025, Contribution ex-TAC is projected to be between $252 million and $258 million, representing 0% to 2% growth at constant currency, with Adjusted EBITDA expected between $69 million and $75 million. The company also reaffirmed Michael Komasinski's appointment as CEO, effective February 15, 2025.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.